KOKH kliinilised uuringud osariigis Alabama
21 uuringut haiguse KOKH jaoks otsivad osalejaid osariigis Alabama.
Linnad osariigis Alabama
Ametlik uuringutekst (inglise keeles)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Cullman
- Research Site, Mobile
VärbamineFaas 3
Vanused 40–80 · Kõik sood · Uuendatud 2. okt 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
- Pulmonary Associates - Mobile- Site Number : 8400151, Mobile
VärbamineFaas 3
Vanused 40–80 · Kõik sood · Uuendatud 1. okt 2026 · NCT07190222A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- University of Alabama at Birmingham, Birmingham
VärbamineFaas 2
Vanused 40–75 · Kõik sood · Uuendatud 25. sept 2026 · NCT07759245A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- University of Alabama at Birmingham - School of Medicine- Site Number : 8400003, Birmingham
VärbamineFaas 4
Vanused 40–85 · Kõik sood · Uuendatud 22. sept 2026 · NCT07053423A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Birmingham
VärbamineFaas 2
Vanused 40 ja vanemad · Kõik sood · Uuendatud 9. sept 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Alabama, Birmingham
VärbamineFaas 2
Vanused 40 ja vanemad · Kõik sood · Uuendatud 4. sept 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Cullman
VärbamineFaas 3
Vanused 40–80 · Kõik sood · Uuendatud 3. sept 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Foley
- Research Site, Mobile
- Research Site, Sheffield
VärbamineFaas 3
Vanused 40–80 · Kõik sood · Uuendatud 3. sept 2026 · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- University of Alabama at Birmingham, Birmingham
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 2. sept 2026 · NCT06603246A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- University of Alabama at Birmingham Lung Health Center, Birmingham
- SEC Clinical Research, Dothan
- Pulmonary Associates of Mobile, P.C., Mobile
VärbamineFaas 2/3
Vanused 35–80 · Kõik sood · Uuendatud 31. aug 2026 · NCT07363694A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 106, Birmingham
VärbamineFaas 3
Vanused 18–80 · Kõik sood · Uuendatud 11. aug 2026 · NCT07555483Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
- Cooper Green Mercy Hospital, Birmingham
VärbamineVaatlusuuring
Vanused 50–99 · Kõik sood · Uuendatud 6. aug 2026 · NCT07748858Multi-Center Clean Air Randomized Controlled Trial in COPD
- University of Alabama, Lung Health Center, Birmingham
VärbamineFaas 3
Vanused 40 ja vanemad · Kõik sood · Uuendatud 31. juuli 2026 · NCT06376994Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
- The University of Alabama at Birmingham, Birmingham
Värbamine
Vanused 22 ja vanemad · Kõik sood · Uuendatud 23. juuni 2026 · NCT07222410SPIROMICS Study of Early COPD Progression (SOURCE)
- University of Alabama at Birmingham, Birmingham
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 30–55 · Kõik sood · Uuendatud 3. juuni 2026 · NCT05033990Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- University of Alabama-Birmingham Hospital - UAB Lung Health Center, Birmingham
Värbamine
Vanused 40–80 · Kõik sood · Uuendatud 28. apr 2026 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- University of Alabama at Birmingham, Birmingham
Värbamine
Vanused 40–84 · Kõik sood · Uuendatud 24. apr 2026 · NCT06891755Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Sheffield
VärbamineFaas 3
Vanused 40–80 · Kõik sood · Uuendatud 9. apr 2026 · NCT06961214PiMZ Longitudinal Cohort (PiMZ Logic)
- University of Alabama at Birmingham, Birmingham
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. jaan 2026 · NCT06505603Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
- University of Alabama at Birmingham, Birmingham
VärbamineFaas 4
Vanused 19 ja vanemad · Kõik sood · Uuendatud 10. nov 2025 · NCT07135427myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- UAB School of Medicine/Lung Health Center, Birmingham
Värbamine
Vanused 30 ja vanemad · Kõik sood · Uuendatud 6. veebr 2025 · NCT05204888Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.